Clinical Trial Update: A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

View source ↗

Summary

This update summarizes the results of a prospective observational study on pregnancy outcomes in women exposed to Truvada for HIV pre-exposure prophylaxis (PrEP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infection | Status: COMPLETED